Effect of Point Spread Function Deconvolution in Reconstruction of Brain 18F-FDG PET Images on the Diagnostic Thinking Efficacy in Alzheimer's Disease

Purpose: This study aims to determine the effect of applying Point Spread Function (PSF) deconvolution, which is known to improve contrast and spatial resolution in brain 18 F-FDG PET images, to the diagnostic thinking efficacy in Alzheimer's disease (AD). Methods: We compared Hoffman 3-D brain...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in medicine Vol. 8; p. 721551
Main Authors Doyen, Matthieu, Mairal, Elise, Bordonne, Manon, Zaragori, Timothée, Roch, Véronique, Imbert, Laetitia, Verger, Antoine
Format Journal Article
LanguageEnglish
Published Frontiers media 29.07.2021
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose: This study aims to determine the effect of applying Point Spread Function (PSF) deconvolution, which is known to improve contrast and spatial resolution in brain 18 F-FDG PET images, to the diagnostic thinking efficacy in Alzheimer's disease (AD). Methods: We compared Hoffman 3-D brain phantom images reconstructed with or without PSF. The effect of PSF deconvolution on AD diagnostic clinical performance was determined from digital brain 18 F-FDG PET images of AD ( n = 38) and healthy ( n = 35) subjects compared to controls ( n = 36). Performances were assessed with SPM at the group level ( p < 0.001 for the voxel) and at the individual level by visual interpretation of SPM T-maps ( p < 0.005 for the voxel) by the consensual analysis of three experienced raters. Results: A mix of large hypometabolic (1,483cm 3 , mean value of −867 ± 492 Bq/ml) and intense hypermetabolic (902 cm 3 , mean value of 1,623 ± 1,242 Bq/ml) areas was observed in the PSF compared to the no PSF phantom images. Significant hypometabolic areas were observed in the AD group compared to the controls, for reconstructions with and without PSF (respectively 23.7 and 26.2 cm 3 ), whereas no significant hypometabolic areas were observed when comparing the group of healthy subjects to the control group. At the individual level, no significant differences in diagnostic performances for discriminating AD were observed visually (sensitivity of 89 and 92% for reconstructions with and without PSF respectively, similar specificity of 74%). Conclusion: Diagnostic thinking efficacy performances for diagnosing AD are similar for 18 F-FDG PET images reconstructed with or without PSF.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC8358179
This article was submitted to Nuclear Medicine, a section of the journal Frontiers in Medicine
Edited by: Domenico Albano, University of Brescia, Italy
Reviewed by: Luca Camoni, University of Brescia, Italy; Alberto Miceli, Università di Genova, Italy
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2021.721551